Stoke Therapeutics, Inc.STOKNASDAQ
Loading
SG&A Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+19.2%
5Y CAGR+25.9%
Year-over-Year Change
Selling, general, and administrative expenses
3Y CAGR
+19.2%/yr
vs +72.4%/yr prior
5Y CAGR
+25.9%/yr
Recent deceleration
Acceleration
-53.2pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
3.2x
Strong expansion
Streak
8 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $65.89M | +35.0% |
| 2024 | $48.79M | +18.1% |
| 2023 | $41.32M | +6.2% |
| 2022 | $38.92M | +22.0% |
| 2021 | $31.90M | +53.0% |
| 2020 | $20.85M | +75.0% |
| 2019 | $11.91M | +170.2% |
| 2018 | $4.41M | +125.5% |
| 2017 | $1.96M | - |